UK NICE recommends Humira as treatment for hidradenitis suppurativa
The National Institute for Health and Care Excellence (NICE) has recommended the use of biopharmaceutical company AbbVie's Humira (adalimumab) for treatment of hidradenitis suppurativa (HS) in adults.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Health | Hidradenitis | Humira | National Institute for Health and Clinical Excelle | Pharmaceuticals